Phase II Iressa Versus Vinorelbine (INVITE)

Clinical Trial ID NCT00256711

PubWeight™ 1.92‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00256711

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE): a randomized, phase II study. J Clin Oncol 2008 1.92
Next 100